233 related articles for article (PubMed ID: 20852028)
1. Metformin treatment may increase omentin-1 levels in women with polycystic ovary syndrome.
Tan BK; Adya R; Farhatullah S; Chen J; Lehnert H; Randeva HS
Diabetes; 2010 Dec; 59(12):3023-31. PubMed ID: 20852028
[TBL] [Abstract][Full Text] [Related]
2. Metformin decreases angiogenesis via NF-kappaB and Erk1/2/Erk5 pathways by increasing the antiangiogenic thrombospondin-1.
Tan BK; Adya R; Chen J; Farhatullah S; Heutling D; Mitchell D; Lehnert H; Randeva HS
Cardiovasc Res; 2009 Aug; 83(3):566-74. PubMed ID: 19414528
[TBL] [Abstract][Full Text] [Related]
3. Plasma omentin-1 levels are reduced in non-obese women with normal glucose tolerance and polycystic ovary syndrome.
Choi JH; Rhee EJ; Kim KH; Woo HY; Lee WY; Sung KC
Eur J Endocrinol; 2011 Nov; 165(5):789-96. PubMed ID: 21865408
[TBL] [Abstract][Full Text] [Related]
4. Examination of angiopoietin-like protein 4, neuropeptide Y, omentin-1 levels of obese and non-obese patients with polycystic ovary syndrome.
Güneş M; Bukan N
Gynecol Endocrinol; 2015; 31(11):903-6. PubMed ID: 26291814
[TBL] [Abstract][Full Text] [Related]
5. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.
Yang HY; Ma Y; Lu XH; Liang XH; Suo YJ; Huang ZX; Lu DC; Qin YF; Luo ZJ
Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948
[TBL] [Abstract][Full Text] [Related]
6. Metformin treatment exerts antiinvasive and antimetastatic effects in human endometrial carcinoma cells.
Tan BK; Adya R; Chen J; Lehnert H; Sant Cassia LJ; Randeva HS
J Clin Endocrinol Metab; 2011 Mar; 96(3):808-16. PubMed ID: 21190977
[TBL] [Abstract][Full Text] [Related]
7. Metformin increases the novel adipokine cartonectin/CTRP3 in women with polycystic ovary syndrome.
Tan BK; Chen J; Hu J; Amar O; Mattu HS; Adya R; Patel V; Ramanjaneya M; Lehnert H; Randeva HS
J Clin Endocrinol Metab; 2013 Dec; 98(12):E1891-900. PubMed ID: 24152681
[TBL] [Abstract][Full Text] [Related]
8. Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome: ex vivo and in vivo regulation of omentin-1 by insulin and glucose.
Tan BK; Adya R; Farhatullah S; Lewandowski KC; O'Hare P; Lehnert H; Randeva HS
Diabetes; 2008 Apr; 57(4):801-8. PubMed ID: 18174521
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory cytokines and chemokines, skeletal muscle and polycystic ovary syndrome: effects of pioglitazone and metformin treatment.
Ciaraldi TP; Aroda V; Mudaliar SR; Henry RR
Metabolism; 2013 Nov; 62(11):1587-96. PubMed ID: 23958241
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of serum level of omentin-1 in females with hirsutism.
Kenawi MZ; Akl EM; Sabry JH; Mostafa ST
J Cosmet Dermatol; 2020 Feb; 19(2):535-539. PubMed ID: 31190433
[TBL] [Abstract][Full Text] [Related]
11. Circulating omentin-1 levels in women with polycystic ovary syndrome: a meta-analysis.
Tang YL; Yu J; Zeng ZG; Liu Y; Liu JY; Xu JX
Gynecol Endocrinol; 2017 Mar; 33(3):244-249. PubMed ID: 27908216
[TBL] [Abstract][Full Text] [Related]
12. Omentin-1 level in adolescents with polycystic ovarian syndrome.
Özgen İT; Oruçlu Ş; Selek S; Kutlu E; Guzel G; Cesur Y
Pediatr Int; 2019 Feb; 61(2):147-151. PubMed ID: 30566253
[TBL] [Abstract][Full Text] [Related]
13. Circulating omentin-1 levels and inflammation in polycystic ovary syndrome.
Franik G; Sadlocha M; Madej P; Owczarek A; Skrzypulec-Plinta V; Plinta R; Chudek J; Olszanecka-Glinianowicz M
Ginekol Pol; 2020; 91(6):308-312. PubMed ID: 32627151
[TBL] [Abstract][Full Text] [Related]
14. Omentin and chemerin and their association with obesity in women with polycystic ovary syndrome.
Guzel EC; Celik C; Abali R; Kucukyalcin V; Celik E; Guzel M; Yilmaz M
Gynecol Endocrinol; 2014 Jun; 30(6):419-22. PubMed ID: 24524360
[TBL] [Abstract][Full Text] [Related]
15. Assessment of serum chemerin, vaspin and omentin-1 levels in patients with polycystic ovary syndrome.
Guvenc Y; Var A; Goker A; Kuscu NK
J Int Med Res; 2016 Aug; 44(4):796-805. PubMed ID: 27225862
[TBL] [Abstract][Full Text] [Related]
16. Comparative effects of metformin and pioglitazone on omentin and leptin concentrations in patients with newly diagnosed diabetes: a randomized clinical trial.
Esteghamati A; Noshad S; Rabizadeh S; Ghavami M; Zandieh A; Nakhjavani M
Regul Pept; 2013 Mar; 182():1-6. PubMed ID: 23328000
[TBL] [Abstract][Full Text] [Related]
17. Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance.
Tan BK; Heutling D; Chen J; Farhatullah S; Adya R; Keay SD; Kennedy CR; Lehnert H; Randeva HS
Diabetes; 2008 Jun; 57(6):1501-7. PubMed ID: 18375437
[TBL] [Abstract][Full Text] [Related]
18. Adipose Tissue-Derived Omentin-1 Function and Regulation.
Watanabe T; Watanabe-Kominato K; Takahashi Y; Kojima M; Watanabe R
Compr Physiol; 2017 Jun; 7(3):765-781. PubMed ID: 28640441
[TBL] [Abstract][Full Text] [Related]
19. Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy.
Teede HJ; Meyer C; Hutchison SK; Zoungas S; McGrath BP; Moran LJ
Fertil Steril; 2010 Jan; 93(1):184-91. PubMed ID: 19019358
[TBL] [Abstract][Full Text] [Related]
20. Plasma omentin and adiponectin levels as markers of adipose tissue dysfunction in normal weight and obese women with polycystic ovary syndrome.
Orlik B; Madej P; Owczarek A; Skałba P; Chudek J; Olszanecka-Glinianowicz M
Clin Endocrinol (Oxf); 2014 Oct; 81(4):529-35. PubMed ID: 24392647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
